Epstein–Barr virus (EBV) has become one of the most intensely studied topics in multiple sclerosis research. But how strong is the evidence linking EBV to MS, and could targeting the virus change the future of treatment and prevention?

In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Prof. Gavin Giovannoni and Prof. Tomas Olsson about the evolving science connecting infections, immunity and multiple sclerosis.

Together, they explore:

This conversation examines one of the most important scientific questions in MS research  and the therapeutic possibilities that may emerge from it.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör The European Committee for Treatment and Research in Multiple Sclerosis. Innehållet i podden är skapat av The European Committee for Treatment and Research in Multiple Sclerosis och inte av, eller tillsammans med, Poddtoppen.